Cargando…

A controlled human malaria infection model enabling evaluation of transmission-blocking interventions

BACKGROUND. Drugs and vaccines that can interrupt the transmission of Plasmodium falciparum will be important for malaria control and elimination. However, models for early clinical evaluation of candidate transmission-blocking interventions are currently unavailable. Here, we describe a new model f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Collins, Katharine A., Wang, Claire Y.T., Adams, Matthew, Mitchell, Hayley, Rampton, Melanie, Elliott, Suzanne, Reuling, Isaie J., Bousema, Teun, Sauerwein, Robert, Chalon, Stephan, Möhrle, Jörg J., McCarthy, James S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Clinical Investigation 2018
Materias:	Clinical Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5873858/ https://www.ncbi.nlm.nih.gov/pubmed/29389671 http://dx.doi.org/10.1172/JCI98012

Ejemplares similares

Controlled human malaria infections by mosquito bites induce more severe clinical symptoms than asexual blood-stage challenge infections
por: Alkema, Manon, et al.
Publicado: (2022)

A Plasmodium vivax experimental human infection model for evaluating efficacy of interventions
por: Collins, Katharine A., et al.
Publicado: (2020)

A Randomized Clinical Trial to Compare Plasmodium falciparum Gametocytemia and Infectivity After Blood-Stage or Mosquito Bite–Induced Controlled Malaria Infection
por: Alkema, Manon, et al.
Publicado: (2020)

Corrigendum to: A Randomized Clinical Trial to Compare Plasmodium falciparum Gametocytemia and Infectivity After Blood-Stage or Mosquito Bite–Induced Controlled Malaria Infection
por: Alkema, Manon, et al.
Publicado: (2020)

DSM265 at 400 Milligrams Clears Asexual Stage Parasites but Not Mature Gametocytes from the Blood of Healthy Subjects Experimentally Infected with Plasmodium falciparum
por: Collins, Katharine A., et al.
Publicado: (2019)

A Single-Dose Combination Study with the Experimental Antimalarials Artefenomel and DSM265 To Determine Safety and Antimalarial Activity against Blood-Stage Plasmodium falciparum in Healthy Volunteers
por: McCarthy, James S., et al.
Publicado: (2019)

Biomarkers of cellular aging during a controlled human malaria infection
por: Miglar, Aurelie, et al.
Publicado: (2021)

In response to the letter to the editor by Dondorp et al. RE: Reuling et al., 2018 ‘liver injury in uncomplicated malaria is an overlooked phenomenon: An observational study’
por: Reuling, Isaie J., et al.
Publicado: (2021)

Concentration of Plasmodium falciparum gametocytes in whole blood samples by magnetic cell sorting enhances parasite infection rates in mosquito feeding assays
por: Reuling, Isaie J., et al.
Publicado: (2017)

The XN-30 hematology analyzer for rapid sensitive detection of malaria: a diagnostic accuracy study
por: Post, Annelies, et al.
Publicado: (2019)

Liver Injury in Uncomplicated Malaria is an Overlooked Phenomenon: An Observational Study
por: Reuling, Isaie J., et al.
Publicado: (2018)

Antimalarial Activity of Artefenomel Against Asexual Parasites and Transmissible Gametocytes During Experimental Blood-Stage Plasmodium vivax Infection
por: Collins, Katharine A, et al.
Publicado: (2020)

A randomized feasibility trial comparing four antimalarial drug regimens to induce Plasmodium falciparum gametocytemia in the controlled human malaria infection model
por: Reuling, Isaie J, et al.
Publicado: (2018)

Functional changes in hemostasis during asexual and sexual parasitemia in a controlled human malaria infection
por: Huang, Shengshi, et al.
Publicado: (2022)

Diagnosis and treatment based on quantitative PCR after controlled human malaria infection
por: Walk, Jona, et al.
Publicado: (2016)

Erratum to: Diagnosis and treatment based on quantitative PCR after controlled human malaria infection
por: Walk, Jona, et al.
Publicado: (2016)

Semi-high-throughput detection of Plasmodium falciparum and Plasmodium vivax oocysts in mosquitoes using bead-beating followed by circumsporozoite ELISA and quantitative PCR
por: Graumans, Wouter, et al.
Publicado: (2017)

Assessing Plasmodium falciparum transmission in mosquito-feeding assays using quantitative PCR
por: Wang, Claire Y. T., et al.
Publicado: (2018)

Antibody Responses to Antigenic Targets of Recent Exposure Are Associated With Low-Density Parasitemia in Controlled Human Plasmodium falciparum Infections
por: van den Hoogen, Lotus L., et al.
Publicado: (2019)

A Phase 1, Placebo-controlled, Randomized, Single Ascending Dose Study and a Volunteer Infection Study to Characterize the Safety, Pharmacokinetics, and Antimalarial Activity of the Plasmodium Phosphatidylinositol 4-Kinase Inhibitor MMV390048
por: McCarthy, James S, et al.
Publicado: (2020)

An inter-laboratory comparison of standard membrane-feeding assays for evaluation of malaria transmission-blocking vaccines
por: Miura, Kazutoyo, et al.
Publicado: (2016)

Assays for quantification of male and female gametocytes in human blood by qRT-PCR in the absence of pure sex-specific gametocyte standards
por: Wang, Claire Y. T., et al.
Publicado: (2020)

Pharmacokinetic/pharmacodynamic modelling of the antimalarial effect of Actelion‐451840 in an induced blood stage malaria study in healthy subjects
por: Krause, Andreas, et al.
Publicado: (2016)

Hitting Hotspots: Spatial Targeting of Malaria for Control and Elimination
por: Bousema, Teun, et al.
Publicado: (2012)

Model-Informed Drug Development for Malaria Therapeutics
por: Andrews, Kayla Ann, et al.
Publicado: (2017)

Population Pharmacokinetics and Pharmacodynamics of Chloroquine in a Plasmodium vivax Volunteer Infection Study
por: Abd‐Rahman, Azrin N., et al.
Publicado: (2020)

A portfolio of geographically distinct laboratory-adapted Plasmodium falciparum clones with consistent infection rates in Anopheles mosquitoes
por: van de Vegte-Bolmer, Marga, et al.
Publicado: (2021)

Modeling the impact of Plasmodium falciparum sexual stage immunity on the composition and dynamics of the human infectious reservoir for malaria in natural settings
por: Ouédraogo, André Lin, et al.
Publicado: (2018)

Overuse of artemisinin-combination therapy in Mto wa Mbu (river of mosquitoes), an area misinterpreted as high endemic for malaria
por: Mwanziva, Charles, et al.
Publicado: (2008)

First‐in‐human clinical trial to assess the safety, tolerability and pharmacokinetics of P218, a novel candidate for malaria chemoprotection
por: Chughlay, M. Farouk, et al.
Publicado: (2020)

The Dynamics of Liver Function Test Abnormalities after Malaria Infection: A Retrospective Observational Study
por: Woodford, John, et al.
Publicado: (2018)

Evaluation of two lead malaria transmission blocking vaccine candidate antibodies in natural parasite-vector combinations
por: Bompard, Anais, et al.
Publicado: (2017)

Efficacy of OZ439 (artefenomel) against early Plasmodium falciparum blood-stage malaria infection in healthy volunteers
por: McCarthy, James S., et al.
Publicado: (2016)

Safety and parasite clearance of artemisinin-resistant Plasmodium falciparum infection: A pilot and a randomised volunteer infection study in Australia
por: Watts, Rebecca E., et al.
Publicado: (2020)

Serologic Markers of Previous Malaria Exposure and Functional Antibodies Inhibiting Parasite Growth Are Associated With Parasite Kinetics Following a Plasmodium falciparum Controlled Human Infection
por: Achan, Jane, et al.
Publicado: (2020)

Safety, tolerability, pharmacokinetics, and activity of the novel long-acting antimalarial DSM265: a two-part first-in-human phase 1a/1b randomised study
por: McCarthy, James S, et al.
Publicado: (2017)

Molecular Markers for Sensitive Detection of Plasmodium falciparum Asexual Stage Parasites and their Application in a Malaria Clinical Trial
por: Tadesse, Fitsum G., et al.
Publicado: (2017)

Protection of Malian children from clinical malaria is associated with recognition of multiple antigens
por: Daou, Modibo, et al.
Publicado: (2015)

Haematological response in experimental human Plasmodium falciparum and Plasmodium vivax malaria
por: Woolley, Stephen D., et al.
Publicado: (2021)

Safety, Tolerability, Pharmacokinetics, and Antimalarial Activity of the Novel Plasmodium Phosphatidylinositol 4-Kinase Inhibitor MMV390048 in Healthy Volunteers
por: Sinxadi, Phumla, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_p5mu81co7fmqkshqm41gpbbdot